CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-01 | FOEHR MATTHEW W President and COO | Option exercise | +12,000 | $14.47 | $174K | 117,388 |
| 2018-10-01 | FOEHR MATTHEW W President and COO | Sale | −12,000 | $273.88 | $3.3M | 105,388 |
| 2018-10-01 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −2,088 | 37,894 | ||
| 2018-10-01 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −12,000 | 21,675 | ||
| 2018-09-17 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +2,813 | $100.38 | $282K | 30,576 |
| 2018-09-17 | Berkman Charles S SVP, Gen. Counsel & Secretary | Sale | −2,813 | $250.69 | $705K | 27,763 |
| 2018-09-17 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise · Employee Stock Option (right to buy) | −2,813 | 6,830 | ||
| 2018-09-04 | Sabba Stephen L Director | Option exercise | +2,500 | $8.58 | $21K | 29,356 |
| 2018-09-04 | Sabba Stephen L Director | Option exercise | +2,500 | $17.88 | $45K | 31,856 |
| 2018-09-04 | Sabba Stephen L Director | Sale | −5,000 | $255.05 | $1.3M | 26,856 |
| 2018-09-04 | Sabba Stephen L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2018-09-04 | Sabba Stephen L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −2,500 | 0 | ||
| 2018-09-04 | FOEHR MATTHEW W President and COO | Option exercise | +1,044 | $9.97 | $10K | 103,300 |
| 2018-09-04 | FOEHR MATTHEW W President and COO | Option exercise | +12,000 | $14.47 | $174K | 115,300 |
| 2018-09-04 | FOEHR MATTHEW W President and COO | Sale | −12,000 | $255.01 | $3.1M | 103,300 |
| 2018-09-04 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −1,044 | 39,982 | ||
| 2018-09-04 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −12,000 | 33,675 | ||
| 2018-09-04 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +469 | $21.92 | $10K | 28,232 |
| 2018-09-04 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +5,985 | $74.42 | $445K | 34,217 |
| 2018-09-04 | Berkman Charles S SVP, Gen. Counsel & Secretary | Option exercise | +7,077 | $56.26 | $398K | 41,294 |
Page 48 of 55 · 1,097 trades